Literature DB >> 6716056

Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency.

U Nägele, E O Hägele, G Sauer, E Wiedemann, P Lehmann, A W Wahlefeld, W Gruber.   

Abstract

A fully enzymatic assay is described for the determination of triglycerides. The coupled activities of triacylglycerol acylhydrolase and glycerol kinase result in the formation of glycerol-3-phosphate. The system also contains L-alpha-glycerol-phosphate oxidase, which produces hydrogen peroxide from glycerol-3-phosphate, and a sensitive chromogenic indicator system, consisting of peroxidase, 4-chlorophenol and 4-aminophenazone. We evaluated this method with respect to kinetics, linearity, blank rates, precision, accuracy, reagent stability and interfering substances. The accuracy of the triglyceride assay demands that each enzymatic reaction step be complete and homogeneous. We therefore developed HPTLC-1) and HPLC-2) methods to monitor the course and completeness of each step.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6716056     DOI: 10.1515/cclm.1984.22.2.165

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  80 in total

1.  Demographic and cardiovascular risk factors modify association of fasting insulin with incident coronary heart disease and ischemic stroke (from the Atherosclerosis Risk In Communities Study).

Authors:  Laura J Rasmussen-Torvik; Hiroshi Yatsuya; Elizabeth Selvin; Alvaro Alonso; Aaron R Folsom
Journal:  Am J Cardiol       Date:  2010-05-15       Impact factor: 2.778

2.  Incidence and risk factors for cardiovascular disease in African Americans with diabetes: the Atherosclerosis Risk in Communities (ARIC) study.

Authors:  Ayokanmi Adeniyi; Aaron R Folsom; Frederick L Brancati; Moise Desvorieux; James S Pankow; Herman Taylor
Journal:  J Natl Med Assoc       Date:  2002-12       Impact factor: 1.798

3.  Nine-year changes in cardiovascular disease risk factors with weight maintenance in the atherosclerosis risk in communities cohort.

Authors:  Kimberly P Truesdale; June Stevens; Jianwen Cai
Journal:  Am J Epidemiol       Date:  2007-01-27       Impact factor: 4.897

4.  Role of apolipoprotein E and B gene variation in determining response of lipid, lipoprotein, and apolipoprotein levels to increased dietary cholesterol.

Authors:  E Boerwinkle; S A Brown; K Rohrbach; A M Gotto; W Patsch
Journal:  Am J Hum Genet       Date:  1991-12       Impact factor: 11.025

5.  Longitudinal changes in triglycerides according to ANGPTL4[E40K] genotype and longitudinal body weight change in the atherosclerosis risk in communities study.

Authors:  Jennifer A Nettleton; Kelly A Volcik; Ellen W Demerath; Eric Boerwinkle; Aaron R Folsom
Journal:  Ann Epidemiol       Date:  2008-09-21       Impact factor: 3.797

6.  Role of thyroid hormones in apolipoprotein A-I gene expression in rat liver.

Authors:  W Strobl; N L Gorder; Y C Lin-Lee; A M Gotto; W Patsch
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

7.  Candidate-gene studies of the atherogenic lipoprotein phenotype: a sib-pair linkage analysis of DZ women twins.

Authors:  M A Austin; P J Talmud; L A Luong; L Haddad; I N Day; B Newman; K L Edwards; R M Krauss; S E Humphries
Journal:  Am J Hum Genet       Date:  1998-02       Impact factor: 11.025

8.  Asthma and incident cardiovascular disease: the Atherosclerosis Risk in Communities Study.

Authors:  J G Schanen; C Iribarren; E Shahar; N M Punjabi; S S Rich; P D Sorlie; A R Folsom
Journal:  Thorax       Date:  2005-08       Impact factor: 9.139

9.  High density lipoprotein2. Relationship of the plasma levels of this lipoprotein species to its composition, to the magnitude of postprandial lipemia, and to the activities of lipoprotein lipase and hepatic lipase.

Authors:  J R Patsch; S Prasad; A M Gotto; W Patsch
Journal:  J Clin Invest       Date:  1987-08       Impact factor: 14.808

10.  Altered regulation of apolipoprotein A-IV gene expression in the liver of the genetically obese Zucker rat.

Authors:  W Strobl; B Knerer; R Gratzl; K Arbeiter; Y C Lin-Lee; W Patsch
Journal:  J Clin Invest       Date:  1993-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.